Therapeutic Proteins

Therapeutic Proteins
Title Therapeutic Proteins PDF eBook
Author Vladimir Voynov
Publisher Humana Press
Pages 516
Release 2016-05-01
Genre Medical
ISBN 9781493959495

Download Therapeutic Proteins Book in PDF, Epub and Kindle

Emphasizing the newest developments in the field, this volume presents detailed methodswith added emphasison therapeutic protein discovery. It features key tips and valuable implementation advice to ensure successful results."

Aggregation of Therapeutic Proteins

Aggregation of Therapeutic Proteins
Title Aggregation of Therapeutic Proteins PDF eBook
Author Wei Wang
Publisher John Wiley & Sons
Pages 400
Release 2010-12-28
Genre Medical
ISBN 1118043588

Download Aggregation of Therapeutic Proteins Book in PDF, Epub and Kindle

This book gives pharmaceutical scientists an up-to-date resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process. While significant progress has been made in the past decade, the current understanding of protein aggregation and its consequences is still immature. Prevention or even moderate inhibition of protein aggregation has been mostly experimental. The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this area. This book fills such a need by providing an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins.

Protein Therapeutics, 2 Volume Set

Protein Therapeutics, 2 Volume Set
Title Protein Therapeutics, 2 Volume Set PDF eBook
Author Tristan Vaughan
Publisher John Wiley & Sons
Pages 762
Release 2017-12-04
Genre Medical
ISBN 3527340866

Download Protein Therapeutics, 2 Volume Set Book in PDF, Epub and Kindle

Branchenführende Big-Pharma-Unternehmen und erstklassige Forscher präsentieren grundlegende Konzepte und Herausforderungen bei proteinbasierten Pharmazeutika. Beinhaltet auch eine Einführung in die aus Sicht der Arzneimittelentwicklung fünf wesentlichen Anwendungsbereiche.

Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins

Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins
Title Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins PDF eBook
Author T. Shantha Raju
Publisher John Wiley & Sons
Pages 324
Release 2019-03-15
Genre Science
ISBN 1119053366

Download Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins Book in PDF, Epub and Kindle

A Comprehensive Guide to Crucial Attributes of Therapeutic Proteins in Biological Pharmaceuticals With this book, Dr. Raju offers a valuable resource for professionals involved in research and development of biopharmaceutical and biosimilar drugs. This is a highly relevant work, as medical practitioners have increasingly turned to biopharmaceutical medicines in their search for safe and reliable treatments for complex diseases, while pharmaceutical researchers seek to expand the availability of biopharmaceuticals and create more affordable biosimilar alternatives. Readers receive a thorough overview of the major co-translational modifications (CTMs) and post-translational modifications (PTMs) of therapeutic proteins relevant to the development of biotherapeutics. The majority of chapters detail individual CTMs and PTMs that may affect the physicochemical, biochemical, biological, pharmacokinetic, immunological, toxicological etc. properties of proteins. In addition, readers are guided on the methodology necessary to analyze and characterize these modifications. Thus, readers gain not only an understanding of CTMs/PTMs, but also the ability to design and assess their own structure-function studies for experimental molecules. Specific features and topics include: Discussion of the research behind and expansion of biopharmaceuticals Twenty chapters detailing relevant CTMs and PTMs of proteins, such as glycosylation, oxidation, phosphorylation, methylation, proteolysis, etc. Each chapter offers an introduction and guide to the mechanisms and biological significance of an individual CTM or PTM, including practical guidance for experiment design and analysis An appendix of biologic pharmaceuticals currently on the market, along with an assessment of their PTMs and overall safety and efficacy This volume will prove a key reference on the shelves of industry and academic researchers involved in the study and development of biochemistry, molecular biology, biopharmaceuticals and proteins in medicine, particularly as biopharmaceuticals and biosimilars become ever more prominent tools in the field of healthcare.

Production of Plasma Proteins for Therapeutic Use

Production of Plasma Proteins for Therapeutic Use
Title Production of Plasma Proteins for Therapeutic Use PDF eBook
Author Joseph Bertolini
Publisher John Wiley & Sons
Pages 518
Release 2012-12-26
Genre Medical
ISBN 0470924314

Download Production of Plasma Proteins for Therapeutic Use Book in PDF, Epub and Kindle

Sets forth the state of the science and technology in plasma protein production With contributions from an international team of eighty leading experts and pioneers in the field, Production of Plasma Proteins for Therapeutic Use presents a comprehensive overview of the current state of knowledge about the function, use, and production of blood plasma proteins. In addition to details of the operational requirements for the production of plasma derivatives, the book describes the biology, development, research, manufacture, and clinical indications of essentially all plasma proteins with established clinical use or therapeutic potential. Production of Plasma Proteins for Therapeutic Use covers the key aspects of the plasma fractionation industry in five sections: Section 1: Introduction to Plasma Fractionation initially describes the history of transfusion and then covers the emergence of plasma collection and fractionation from its earliest days to the present time, with the commercial and not-for-profit sectors developing into a multi-billion dollar industry. Section 2: Plasma Proteins for Therapeutic Use contains 24 chapters dedicated to specific plasma proteins, including coagulation factors, albumin, immunoglobulin, and a comprehensive range of other plasma-derived proteins with therapeutic indications. Each chapter discusses the physiology, biochemistry, mechanism of action, and manufacture of each plasma protein including viral safety issues and clinical uses. Section 3: Pathogen Safety of Plasma Products examines issues and procedures for enhancing viral safety and reducing the risk of transmissible spongiform encephalopathy transmission. Section 4: The Pharmaceutical Environment Applied to Plasma Fractionation details the requirements and activities associated with plasma collection, quality assurance, compliance with regulatory requirements, provision of medical affairs support, and the manufacture of plasma products. Section 5: The Market for Plasma Products and the Economics of Fractionation reviews the commercial environment and economics of the plasma fractionation industry including future trends, highlighting regions such as Asia, which have the potential to exert a major influence on the plasma fractionation industry in the twenty-first century.

Therapeutic Fc-Fusion Proteins

Therapeutic Fc-Fusion Proteins
Title Therapeutic Fc-Fusion Proteins PDF eBook
Author Steven M. Chamow
Publisher John Wiley & Sons
Pages 345
Release 2013-12-18
Genre Science
ISBN 3527675280

Download Therapeutic Fc-Fusion Proteins Book in PDF, Epub and Kindle

Edited by three pioneers in the field, each with longstanding experience in the biotech industry, and a skilled scientific writer, this is the first book to cover every step in the development and production of immunoglobulin Fc-fusion proteins as therapeutics for human disease: from choosing the right molecular design, to pre-clinical characterization of the purified product, through to batch optimization and quality control for large-scale cGMP production. The whole of the second part is devoted to case studies of Fc-fusion proteins that are now commercially successful products. In this section, the authors, several of whom were personally involved in clinical development of the products themselves, detail the product?s background and give insight into issues that were faced and how these issues were overcome during clinical development. This section also includes a chapter on promising new developments for the future. An invaluable resource for professionals already working on Fc-fusion proteins and an excellent and thorough introduction for physicians, researchers, and students entering the field.

Therapeutic Protein Drug Products

Therapeutic Protein Drug Products
Title Therapeutic Protein Drug Products PDF eBook
Author Brian K Meyer
Publisher Woodhead Publishing
Pages 0
Release 2012-01-02
Genre Medical
ISBN 9781907568183

Download Therapeutic Protein Drug Products Book in PDF, Epub and Kindle

Therapeutic protein drug products provides a comprehensive overview of therapeutic protein drug products, with an emphasis on formulation beginning in the laboratory, followed by manufacturing and administration in the clinic. A list of many commercial therapeutic drug products are described and include the product name, dosages, active concentration, buffer, excipients, Ph, container type and route of administration. The laboratory formulation sections focus on the most common buffers, excipients, and Ph ranges that are commonly tested in addition to systematic approaches. A brief section on biophysical and analytical analysis is also provided. Properties of therapeutic protein formulations are described and include opalescence, phase separation, color, and subvisible particles. An emphasis is placed on material and process testing to ensure success during manufacturing. The drug product manufacturing process, which includes the process of compounding to filling, is also covered. Methods of delivery in the clinic are addressed, as well as delivery strategies. Finally, a perspective on the regulatory requirements for therapeutic protein formulations is discussed.